ZERO Prostate Cancer FY 2022-23 Annual Report

ZERO’s Leadership

FY 2022-23 Financials APRIL 1, 2022 - MARCH 31, 2023 Gross Income $9,365,841 Gross Expenses -$10,407,106

2022 Board of Directors

ZERO Management Team

Tom Bognanno Chair Alicia Morgans, M.D., M.P.H. Vice Chair Ed Lomasney Secretary/Treasurer

Courtney Bugler, C.F.R.E. President and CEO* Colony Brown Chief Marketing Officer* Tracy Cesaretti Vice President, Events Jen Gomes Vice President, Operations

Ali Manson Vice President Government Relations

Brad D. Lerner, M.D., F.A.C.S., C.A.S.C. Sandra Maxey Kelvin Moses, M.D., Ph.D., F.A.C.S. Cheryl Nikituk Daniel Perkins Jon Poindexter James Schraidt Jonathan D. Schwartz Donald Slaght

and Advocacy Shelby Moneer Vice President Patient Programs and Education *Executive Team Members

Profit/Loss

-$1,041,265

Assets Total Assets

Teedra Bernard Marty Chakoian Alan Goldman Karen Jauregui

$7,317,310 -$1,453,845

Total Liabilities

Net Assets

$5,853,465

Medical Advisory Board

SPENDING

SPENDING BY PROGRAM CATEGORY

85.5% PROGRAM EXPENSES $8,900,412 5%

64.3% EDUCATION & AWARENESS $5,723,834 2.2% RESEARCH $194,452 17.2%

Kelvin Moses, M.D., Ph.D. Vanderbilt University Medical Center Rachel S. Rubin, M.D. Assistant Clinical Professor in Urology at Georgetown University Charles J. Ryan, M.D. Prostate Cancer Foundation Alison Sachs, M.S.W., C.S.W., O.S.W.-C. Eisenhower Lucy Curci Cancer Center Eric Shinohara, M.D., M.S.C.I. Vanderbilt University Medical Center

Alicia Morgans, M.D., M.P.H. (Chair) Dana-Farber Cancer Institute Joanna Doran, Esq. Triage Cancer Nilay M. Gandhi, M.D. Potomac Urology Inova Alexandria Hospital Elisabeth Heath, M.D., F.A.C.P. Wayne State University

Stacy Loeb, M.D., M.S.c., Ph.D. (Hon) New York University School of Medicine and the Manhattan Veterans Affairs Medical Center Benjamin H. Lowentritt, M.D., F.A.C.S. Chesapeake Urology Associates and Director of the Minimally Invasive and Robotic Surgery Group at Chesapeake Urology

ADMINISTRATIVE EXPENSES $518,703

ZERO is a 501(c)(3) philanthropic organization recognized with four out of four stars by Charity Navigator and is accredited by the Better Business Bureau.

PATIENT SUPPORT $1,530,347 16.3% ADVOCACY $1,451,779

9.5% FUNDRAISING EXPENSES $987,991

School of Medicine Laurence Klotz, M.D. University of Toronto

Meredith Morgan, M.S.N. Urology Oncology Clinic, University of Michigan

Comprehensive Cancer Center

TOTAL: $10,407,106

TOTAL: $8,900,412

*In fiscal year 2022-2023, ZERO Prostate Cancer made additional investments in organizational capacity, which were approved by ZERO’s Board of Directors.

Made with FlippingBook flipbook maker